In addition, decreased FTO takes a tumorigenic role in bladder cancer 32 and a highly selective inhibitor of FTO could restrain the cisplatin-induced cytotoxicity in bladder cancer cells 33. This evidence concerns the gene FTO and urinary bladder cancer.